Clemastine Fumarate

4 trials 3 recruiting RRespiratory

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

3 Recruiting

0 Completed trials

4 Sponsors

12 Countries

Phase III

Phase II

Phase I

Phase III: 1 Phase II: 2 Phase I: 1

Oversight events:

4 temporary halts 1 corrective measure across 2 trials

View oversight register →

Indications tested

Breast cancer 1 Osteosarcoma 1 Neuroblastoma 1 Ewing's sarcoma 1 Epidermolysis bullosa 1 Pitt-Hopkins syndrome 1

Sponsors using this IMP

Amsterdam UMC Stichting 1 Poltreg S.A. 1 Rheacell GmbH & Co. KG 1 Universitaet Muenster 1

All trials

4 total

A randomized, placebo-controlled trial to assess the efficacy, tolerability, and pharmacokinetics of clemastine in children and adults with … Pending

2025-524195-29-00 Phase II 1 country Amsterdam UMC Stichting
Phase III clinical trial of ABCB5+ MSCs for the treatment of EB Recruiting

2022-500266-10-00 Phase III 12 countries Rheacell GmbH & Co. KG
A multicenter, randomized, blinded, placebo controlled, phase II study to evaluate the safety and efficacy of cell therapy based with artifi… Recruiting

2023-505226-33-00 Phase II 1 country Poltreg S.A.
A phase I safety, dose finding and feasibility trial of GD2IL18CART in patients with relapsed or refractory GD2 positive solid cancers Recruiting

2022-501725-21-00 Phase I 1 country Universitaet Muenster

Showing 1–4 of 4 trials

← All drugs A–Z